TFII-I inhibitors belong to a specific chemical class that targets the transcription factor II-I (TFII-I) proteins. Transcription factors are essential regulatory proteins that modulate gene expression by controlling the transcription of specific genes. TFII-I, in particular, plays a significant role in this process, as it regulates the activity of various genes involved in critical cellular functions. TFII-I is known to be involved in the control of cell proliferation, differentiation, and apoptosis, making it a promising target for research in various fields. TFII-I inhibitors are chemical compounds designed to selectively bind to TFII-I proteins, thereby disrupting their normal function. By inhibiting the activity of TFII-I, these compounds can potentially influence gene expression patterns and impact cellular processes in a controlled manner. This selective interference with TFII-I's regulatory role can lead to a better understanding of the intricate molecular mechanisms that govern cellular functions.
Due to their specialized nature, TFII-I inhibitors are subject to rigorous testing and evaluation in the scientific community. Researchers are particularly interested in exploring the potential of these inhibitors in gaining insights into various biological processes, including cell development, tissue repair, and disease progression. Understanding the impact of TFII-I inhibition may pave the way for novel discoveries in cell biology and open up new avenues for targeted molecular interventions. As research in the field progresses, scientists are continuously optimizing TFII-I inhibitors to enhance their specificity and efficacy. By further elucidating the interactions between these inhibitors and TFII-I proteins, researchers aim to expand our knowledge of gene regulation, transcriptional control, and their relevance in health and disease. Overall, TFII-I inhibitors represent a fascinating class of chemical compounds with great potential to deepen our understanding of cellular processes and may eventually offer new perspectives on biomedical research.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ciclopirox | 29342-05-0 | sc-217893 | 25 mg | $207.00 | 2 | |
Ciclopirox is an antifungal and anti-inflammatory agent that has been shown to inhibit TFII-I activity. It is used primarily for fungal infections but has also demonstrated potential as a TFII-I inhibitor. | ||||||
CX-4945 | 1009820-21-6 | sc-364475 sc-364475A | 2 mg 50 mg | $183.00 $800.00 | 9 | |
CX-4945 is a potent and selective inhibitor of protein kinase CK2, which has been found to downregulate TFII-I activity. | ||||||
6-Thioguanine | 154-42-7 | sc-205587 sc-205587A | 250 mg 500 mg | $42.00 $54.00 | 3 | |
6-thioguanine is an immunosuppressive drug that has been found to inhibit TFII-I activity. | ||||||
Benzyl isothiocyanate | 622-78-6 | sc-204641 sc-204641A | 5 g 25 g | $47.00 $156.00 | 1 | |
This natural compound found in cruciferous vegetables, such as broccoli and cabbage, has been identified as a TFII-I inhibitor. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide is a diterpene triepoxide found in the Chinese medicinal herb Tripterygium wilfordii. | ||||||
Thioridazine | 50-52-2 | sc-473180 | 50 mg | $500.00 | ||
Thioridazine is an antipsychotic drug that has been shown to inhibit TFII-I activity. | ||||||
JIB 04 | 199596-05-9 | sc-397040 | 20 mg | $177.00 | ||
JIB-04 is a small-molecule inhibitor that targets the lysine-specific demethylase 4 (LSD1). By inhibiting LSD1, JIB-04 indirectly affects TFII-I function and has been investigated for its anti-cancer effects. | ||||||
Emetine | 483-18-1 | sc-470668 sc-470668A sc-470668B sc-470668C | 1 mg 10 mg 50 mg 100 mg | $440.00 $900.00 $1400.00 $2502.00 | ||
Emetine is an alkaloid found in the ipecac root and has been identified as a TFII-I inhibitor. | ||||||
Andrographolide | 5508-58-7 | sc-205594 sc-205594A | 50 mg 100 mg | $15.00 $40.00 | 7 | |
Andrographolide is a bioactive compound found in Andrographis paniculata, a medicinal plant. It has been reported to inhibit TFII-I activity and has potential anti-inflammatory and anti-cancer effects. | ||||||